Rallybio Corporation

NASDAQ:RLYB

Biotechnology

Healthcare
$15.52 +0.03%

+$0.01 today

Market cap
$83.56M
Beta
-0.88
P/E (TTM)
-11.6
EPS (TTM)
-$1.37
52W Low $2.40High $17.57

Volume 0.04M

Average 0.25M

Income Statement

Follow revenue through to earnings.

Revenue

$858,000.00

FY 2025 · Annual

+34.9% YoY

Operating Income

-$28.06M

FY 2025 · Annual

Net Income

-$8.98M

FY 2025 · Annual

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue000636K858K
Cost of Revenue109K167K150K131K92K
Gross Profit(109K)(167K)(150K)636K766K
Gross Margin———100.0%89.3%
Research & Development26.91M40.69M53.54M41.51M19.6M
Selling, General & Admin18.74M27.2M25.39M19.63M14.33M
Operating Expenses45.65M67.88M78.93M61.13M28.83M
Depreciation & Amortization109K167K150K131K92K
EBITDA(45.39M)(67.72M)(78.78M)(60.37M)(27.97M)
EBITDA Margin———-9491.4%-3260.1%
Operating Income(45.65M)(67.88M)(78.93M)(60.5M)(28.06M)
Operating Margin———-9511.9%-3270.9%
Interest Income54K1.96M6.15M4.22M2.19M
Interest Expense10K0000
Other Income / Expenses(1.37M)1.23M4.37M2.72M19.09M
Income Before Tax(47.01M)(67.73M)(74.56M)(57.78M)(8.98M)
Pre-Tax Margin———-9084.1%-1046.4%
Income Tax Expense0(1.08M)000
Net Income(47.01M)(66.65M)(74.56M)(57.78M)(8.98M)
Net Margin———-9084.1%-1046.4%
EPS (Basic)(11.68)(16.72)(14.72)(10.64)(1.59)
EPS (Diluted)(11.68)(16.72)(14.72)(10.64)(1.59)
Weighted Avg Shares4.02M3.98M5.06M5.44M5.63M
Weighted Avg Shares (Diluted)4.02M3.98M5.06M5.44M5.63M

RLYB Earnings Waterfall · TTM

NASDAQ:RLYB · Revenue to Net Income

Key Ratios

EPS$-1.49
Gross Margin99.6%
Net Margin-890.7%
P/E Ratio-0.7
P/S Ratio137.2

Analysis

$858.0K of revenue converted into -$7.8M of net income for the selected period. Gross margin is 99.6% and net margin is -890.7%, showing how much revenue survives after costs and taxes. EPS is $-1.49, tying the income statement back to per-share earnings.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
8-KCurrent reportNov 12, 2026
425425 filingNov 12, 2026
8-KCurrent reportNov 10, 2026
425425 filingNov 10, 2026
8-KCurrent reportNov 6, 2026

How much revenue does RLYB generate?

Rallybio Corporation (RLYB) reported $858,000.00 of revenue in fiscal 2025.

Is RLYB profitable?

Rallybio Corporation (RLYB) reported -$8.98M of net income, with a net margin of -1046.4%.